---
title: "Prostate Cancer Clinical Trials in Houston"
description: "Find 517 clinical trials for prostate cancer near Houston, Texas. Connect with research centers in your area."
url: "https://www.clareohealth.com/clinical-trials/condition/prostate-cancer/houston"
---

# Prostate Cancer Clinical Trials in Houston

Find 517 clinical trials for prostate cancer near Houston, Texas. Connect with research centers in your area.

- [All Prostate Cancer trials nationwide](https://www.clareohealth.com/clinical-trials/condition/prostate-cancer)
- [All trials in Houston](https://www.clareohealth.com/clinical-trials/location/houston)

Showing 1-20 of 517 trials

### [A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations](https://www.clareohealth.com/clinical-trials/NCT07038369)

Status: ACTIVE_NOT_RECRUITING · Phase: PHASE1 · NCT07038369 · Los Angeles, California and 7 others · Sponsor: Atavistik Bio, Inc

This is a Phase 1, open-label study to evaluate the safety and tolerability of ATV-1601 administered orally in adults with AKT1 E17K-mutant, advanced solid tumors and also in HR+/H…

### [Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer](https://www.clareohealth.com/clinical-trials/NCT04947254)

Status: RECRUITING · Phase: PHASE2 · NCT04947254 · Houston, Texas · Sponsor: M.D. Anderson Cancer Center

This phase II trial studies the effect of androgen ablation therapy with or without niraparib after standard of care radiation therapy in treating patients with prostate cancer tha…

### [Docetaxel Followed by Provenge in Metastatic Prostate Cancer](https://www.clareohealth.com/clinical-trials/NCT02793765)

Status: WITHDRAWN · Phase: PHASE2 · NCT02793765 · Houston, Texas · Sponsor: The University of Texas Health Science Center, Houston

This clinical study will evaluate the role of combination therapy of docetaxel followed by Provenge for patients with metastatic castration-resistant prostate cancer (CRPC, (prosta…

### [A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer](https://www.clareohealth.com/clinical-trials/NCT06095089)

Status: RECRUITING · Phase: PHASE1 · NCT06095089 · Aurora, Colorado and 21 others · Sponsor: Janssen Research & Development, LLC

The purpose of Parts 1, 2A, and 2B of the study is to determine the recommended regimen for Phase 2 (RP2Rs) of combination of JNJ-87189401 with JNJ-78278343 and the purpose of Part…

### [An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)](https://www.clareohealth.com/clinical-trials/NCT02257736)

Status: ACTIVE_NOT_RECRUITING · Phase: PHASE3 · NCT02257736 · Phoenix, Arizona and 172 others · Sponsor: Aragon Pharmaceuticals, Inc.

The purpose of this study is to compare the radiographic progression-free survival (rPFS) of apalutamide in combination with abiraterone acetate (AA) plus prednisone or prednisolon…

### [Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP (FORMULA-509)](https://www.clareohealth.com/clinical-trials/NCT03141671)

Status: UNKNOWN · Phase: PHASE2 · NCT03141671 · San Diego, California and 7 others · Sponsor: Dana-Farber Cancer Institute

This research study is comparing two different combinations of androgen deprivation therapy (ADT) used together with radiation as a treatment for rising PSA after radical prostatec…

### [IDOV-Immune for Advanced Solid Tumors](https://www.clareohealth.com/clinical-trials/NCT06910657)

Status: RECRUITING · Phase: PHASE1 · NCT06910657 · St Louis, Missouri and 4 others · Sponsor: ViroMissile, Inc.

This is a Phase I clinical trial evaluating an investigational treatment called IDOV-Immune, a type of oncolytic virus therapy, for adults with advanced solid tumors that have not…

### [Sunitinib Malate With Hormonal Ablation for Patients Who Will Have Prostatectomy](https://www.clareohealth.com/clinical-trials/NCT00329043)

Status: ACTIVE_NOT_RECRUITING · Phase: PHASE2 · NCT00329043 · Houston, Texas · Sponsor: M.D. Anderson Cancer Center

The goal of this clinical research study is to learn if the addition of sunitinib malate (SU011248) to hormone based castration is an effective treatment for shrinking or controlli…

### [Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate Cancer](https://www.clareohealth.com/clinical-trials/NCT03697148)

Status: ACTIVE_NOT_RECRUITING · Phase: NA · NCT03697148 · Phoenix, Arizona and 43 others · Sponsor: ECOG-ACRIN Cancer Research Group

This phase II trial studies how well multiparametric magnetic resonance imaging (MRI) works in evaluating cancer stage and helping treatment planning in patients with prostate canc…

### [Early Stage Prostate Cancer Cohort](https://www.clareohealth.com/clinical-trials/NCT00011349)

Status: COMPLETED · NCT00011349 · Tucson, Arizona and 12 others · Sponsor: US Department of Veterans Affairs

Environmental factors such as diet and cigarette smoking may play a role in predicting the progression of early stage prostate cancer to advance disease.

### [A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer](https://www.clareohealth.com/clinical-trials/NCT06533644)

Status: ACTIVE_NOT_RECRUITING · Phase: PHASE2 · NCT06533644 · Phoenix, Arizona and 22 others · Sponsor: Syncromune, Inc.

The primary purpose of this study is to evaluate the safety, tolerability, and efficacy of SYNC-T Therapy SV-102 and to identify the maximum tolerated dose (MTD) and/or selected do…

### [Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer](https://www.clareohealth.com/clinical-trials/NCT01981109)

Status: TERMINATED · NCT01981109 · Anchorage, Alaska and 57 others · Sponsor: Dendreon

The primary purpose of this research is to describe patient characteristics predictive of an imaging study positive for distant metastases in patients with castration-resistant pro…

### [Study of Cabozantinib (XL184) in Adults With Advanced Malignancies](https://www.clareohealth.com/clinical-trials/NCT00940225)

Status: COMPLETED · Phase: PHASE2 · NCT00940225 · Scottsdale, Arizona and 46 others · Sponsor: Exelixis

This is a Phase 2 study to evaluate the efficacy and safety of cabozantinib (XL184) in subjects with selected advanced tumor types.

### [Dose-finding Study of GSK2636771 When Administered in Combination With Enzalutamide in Male Subjects With Metastatic Castration-Resistant Prostate Cancer](https://www.clareohealth.com/clinical-trials/NCT02215096)

Status: COMPLETED · Phase: PHASE1 · NCT02215096 · Duarte, California and 8 others · Sponsor: GlaxoSmithKline

This Phase I, open-label, dose-finding, multicenter study is designed to determine the recommended Phase II dose (RP2D) for the combination of an orally administered Phosphatidylin…

### [Evaluating Symptom Management Educational Materials for Patients With Prostate Cancer](https://www.clareohealth.com/clinical-trials/NCT00769431)

Status: COMPLETED · Phase: NA · NCT00769431 · Houston, Texas and 1 other · Sponsor: Baylor College of Medicine

RATIONALE: Collecting feedback from patients with prostate cancer may help doctors develop better symptom management educational materials for patients.

### [Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer](https://www.clareohealth.com/clinical-trials/NCT03860272)

Status: ACTIVE_NOT_RECRUITING · Phase: PHASE1 · NCT03860272 · Scottsdale, Arizona and 17 others · Sponsor: Agenus Inc.

This study is an open-label, Phase 1, multicenter study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamic (PD) profiles of a novel fragment crystalli…

### [Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord](https://www.clareohealth.com/clinical-trials/NCT02713269)

Status: ACTIVE_NOT_RECRUITING · Phase: PHASE2 · NCT02713269 · Houston, Texas · Sponsor: M.D. Anderson Cancer Center

This phase II clinical trial studies how well thermal ablation and spine stereotactic radiosurgery work in treating patients with cancer that has spread to the spine (spine metasta…

### [Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC](https://www.clareohealth.com/clinical-trials/NCT04821622)

Status: ACTIVE_NOT_RECRUITING · Phase: PHASE3 · NCT04821622 · Birmingham, Alabama and 311 others · Sponsor: Pfizer

The purpose of the study is to evaluate the safety and efficacy of talazoparib in combination with enzalutamide compared with placebo in combination with enzalutamide in participan…

### [Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer](https://www.clareohealth.com/clinical-trials/NCT00657904)

Status: COMPLETED · Phase: PHASE3 · NCT00657904 · Birmingham, Alabama and 84 others · Sponsor: AstraZeneca

The purpose of this trial is to study the effect - in terms of time to progression and overall survival - of 2 years of adjuvant bicalutamide 150mg monotherapy, versus placebo, in…

### [An Investigational Scan (18F-Fluciclovine PET-CT) for the Measurement of Therapeutic Response in Patients With Metastatic Prostate Cancer](https://www.clareohealth.com/clinical-trials/NCT04134208)

Status: TERMINATED · Phase: PHASE4 · NCT04134208 · Houston, Texas · Sponsor: M.D. Anderson Cancer Center

This phase IV trial studies how well an investigational scan (18F-fluciclovine PET-CT) works for the measurement of therapeutic response in patients with prostate cancer that has s…

## Prostate Cancer Trials in Other Cities

- [New York](https://www.clareohealth.com/clinical-trials/condition/prostate-cancer/new-york)
- [Los Angeles](https://www.clareohealth.com/clinical-trials/condition/prostate-cancer/los-angeles)
- [Chicago](https://www.clareohealth.com/clinical-trials/condition/prostate-cancer/chicago)
- [Phoenix](https://www.clareohealth.com/clinical-trials/condition/prostate-cancer/phoenix)
- [Philadelphia](https://www.clareohealth.com/clinical-trials/condition/prostate-cancer/philadelphia)
- [San Antonio](https://www.clareohealth.com/clinical-trials/condition/prostate-cancer/san-antonio)

## Other Conditions in Houston

- [Breast Cancer](https://www.clareohealth.com/clinical-trials/condition/breast-cancer/houston)
- [Lung Cancer](https://www.clareohealth.com/clinical-trials/condition/lung-cancer/houston)
- [Colorectal Cancer](https://www.clareohealth.com/clinical-trials/condition/colorectal-cancer/houston)
- [Melanoma](https://www.clareohealth.com/clinical-trials/condition/melanoma/houston)
- [Leukemia](https://www.clareohealth.com/clinical-trials/condition/leukemia/houston)
- [Lymphoma](https://www.clareohealth.com/clinical-trials/condition/lymphoma/houston)

Data from [ClinicalTrials.gov](https://clinicaltrials.gov).

---

## Sitemap

This is the Markdown version of https://www.clareohealth.com/clinical-trials/condition/prostate-cancer/houston.

- [Home](https://www.clareohealth.com/index.md)
- [About](https://www.clareohealth.com/about.md)
- [Pricing](https://www.clareohealth.com/pricing.md)
- [For providers](https://www.clareohealth.com/providers.md)
- [FAQ](https://www.clareohealth.com/faq.md)
- [Blog](https://www.clareohealth.com/blog.md)
- [Clinical trials](https://www.clareohealth.com/clinical-trials.md)
- [Developers](https://www.clareohealth.com/developers.md)
- [Privacy policy](https://www.clareohealth.com/legal/privacy-policy.md)
- [Terms of service](https://www.clareohealth.com/legal/terms-of-service.md)
- [Every page](https://www.clareohealth.com/sitemap.md)
- [About this site, for agents](https://www.clareohealth.com/llms.txt)
